The dynamics of T cell receptor signaling: Complex orchestration and the key roles of tempo and cooperation

Annual Review of Immunology

Volumn 17, Issue , 1999, Pages 467-522

  Germain, Ronald N ^a   Štefanová, Irena ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antagonists; Feedback regulation; Kinetic proofreading

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN; MEMBRANE RECEPTOR; T LYMPHOCYTE RECEPTOR;

BINDING AFFINITY; CELL PROLIFERATION; FEEDBACK SYSTEM; IMMUNOMODULATION; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR OCCUPANCY; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIFFERENTIATION; FEEDBACK; HISTOCOMPATIBILITY ANTIGENS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; LYMPHOCYTE ACTIVATION; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; PEPTIDES; PHENOTYPE; PHOSPHORYLATION; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTOR CROSS-TALK; RECEPTORS, ANTIGEN, T-CELL; SHP1 PROTEIN TYROSINE PHOSPHATASE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0032968708     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.17.1.467     Document Type: Review

References (271)

1. Davis MM, Bjorkman PJ. 1988. T-cell antigen receptor genes and T-cell recognition. Nature 334:395-402
2. Ito K, Van KL, Bonneville M, Hsu S, Murphy DB, Tonegawa S. 1990. Recognition of the product of a novel MHC TL region gene (27b) by a mouse γ δ T cell receptor. Cell 62:549-61
3. O'Brien RL, Fu YX, Cranfill R, Dallas A, Ellis C, Reardon C, Lang J, Carding SR, Kubo R, Born W. 1992. Heat shock protein Hsp60-reactive γδ-cells -A large, diversified T lymphocyte subset with highly focused specificity. Proc. Natll. Acad. Sci. USA 89:4348-52
4. Schild H, Mavaddat N, Litzenberger C, Ehrich EW, Davis MM, Bluestone JA, Matis L, Draper RK, Chien YH. 1994. The nature of major histocompatibility complex recognition by γδ T cells. Cell 76:29-37
5. Germain RN. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287-99
6. Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. 1994. Recognition of a lipid antigen by CD1-restricted αβ+ T cells. Nature 372:691-94
7. Sieling PA, Chatterjee D, Porcelli SA, Prigozy TI, Mazzaccaro RJ, Soriano T, Bloom BR, Brenner MB, Kronenberg M, Brennan PJ, Modlin RL. 1995. GD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269:227-30
8. Prigozy TI, Sieling PA, Clemens D, Stewart PL, Behar SM, Porcelli SA, Brenner MB, Modlin RL, Kronenberg M. 1997. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 6:187-97
9. Stern LJ, Wiley DC. 1994. Antigenic peptide binding by class I and class II histocompatibility proteins. Structure 2:245-51
10. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33-39
11. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. 1987. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329:512-18
12. Garrett TP, Saper MA, Bjorkraan PJ, Stromingcr JL, Wiley DC. 1989. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 342:692-96
13. Matsumura M, Fremont DH, Peterson PA, Wilson IA. 1992. Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257:927-34
14. Falk K, Rötzschke O, Stevanovic S, Jung G, Rammensee HG. 1991. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290-96
15. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. 1994, Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 39:230-42
16. Hammer J, Bono E, Gallazzi F, Belunis C, Nagy Z, Sinigaglia F. 1994. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J. Exp. Med. 180:2353-58
17. Sinigaglia F, Hammer J. 1995. Motifs and supermotifs for MHC class II binding peptides. J. Exp. Med. 181:449-51
18. Cerundolo V, Elliott T, Elvin J, Bastin J, Rammensee HG, Townsend A, 1991. The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules, Eur. J. Immunol. 21:2069-75
19. Yewdell JW, Bennink JR. 1999. Immunodominance in MHC class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17: In press
20. Wang CR, Fischer-Lindahl K, Deisenhofer J. 1996. Crystal structure of the MHC class Ib molecule H2-M3. Res. Immunol. 147:313-21
21. Rudensky A, Preston HP, Hong SC, Barlow A, Janeway CA Jr. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622-27
22. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DA, Strominger JL. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764-68
23. d. Science 256:1817-20
24. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, Cox AL, Appella E, Engelhard VH. 1992. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261-63
25. Rötzschke O, Falk K, Deres K, Schild H, Norda M, Metzger J, Jung G, Rammensce HG. 1990. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 348:252-54
26. b molecule. Nature 348:213-16
27. Porgador A, Yewdell JW, Deng Y, Bennink JR, Germain RN. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6:715-26
28. Anton LC, Yewdell JW, Bennink JR. 1997. MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies. J. Immunol. 158:2535-42
29. Demotz S, Grey HM, Sette A. 1990. The minimal number of class II MHC-antigen complexes needed for T cell activation. Science 249:1028-30
30. Harding CV, Unanue ER. 1990. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature 346:574-76
31. Christinck ER, Luscher MA, Barber BH, Williams DB. 1991. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature 352:67-70
32. Sykulev Y, Joo M, Vturina I, Tsomides TJ, Eisen HN. 1996. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4:565-71
33. Schodin BA, Tsomides TJ, Kranz DM. 1996. Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity. Immunity 5:137-46
34. Madden DR, Garboczi DN, Wiley DC. 1993. The antigenic identify of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75:693-708
35. Fremont DH, Hendrickson WA, Marrack P, Kappler J. 1996. Structures of an MHC class II molecule with covalently bound single peptides, Science 272:1001-4
36. k in complex with a dominant cpitopc of lysozyme. Immunity 8:305-17
37. h, Science 257:919-27
38. Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA. 1996. An αβ T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 274:209-19
39. Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134-41
40. d peptide complexes. Immunity 8:553-62
41. Garcia KC, Degano M, Pease LR, Huang M, Peterson PA, Teyton L, Wilson IA. 1998. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279:1166-72
42. Ding YH, Smith KJ, Garboczi DN, Utz U, Biddison WE, Wiley DC. 1998. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 8:403-11
43. Teng MK, Smolyar A, Tse AG, Liu JH, Liu J, Hussey RE, Nathenson SG, Chang HC, Reinherz LL, Wang JH. 1998. Identification of a common docking topology with substantial variation among different TCR-peptide-MHC complexes. Curr. Biol. 8:409-12
44. Roboy E, Fowlkes BJ. 1994. Selective events in T cell development. Annu. Rev. Immunol. 12:675-705
45. Germain RN. 1990, Making a molecular match. Nature 344:19-22
46. Germain RN. 1993, Antigen processing and presentation. In Fundamental Immunology, ed. WE Paul, pp. 629-76. New York: Raven, 3rd ed.
47. Zerrahn J, Held W, Raulet DH. 1997. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell 88:627-36
48. Merkenschlager M, Graf D, Lovatt M, Bommhardt U, Zamoyska R, Fisher AG. 1997. How many thymocytes audition for selection? J. Exp. Med. 186:1149-58
49. Jerne NK. 1971. The somatic generation of immune recognition. Eur. J. Immunol. 1:1-9
50. Tanchot C, Lemonnier FA, Perarnau B, Freitas AA, Rocha B. 1997. Differential requirements for survival and proliferation of CDS naive or memory T cells. Science 276:2057-62
51. Kirberg J, Berns A, von Bochmer H. 1997. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J. Exp. Med. 186:1269-75
52. Brocker T. 1997. Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells. J. Exp. Med. 186:1223-32
53. Rooke R, Walzinger C, Benoist C, Mathis D. 1997. Targeted complementation of MHC class II deficiency by intrathymic delivery of recombinant adenoviruses. Immunity 7:123-34
54. Markiewicz, MA, Girao C, Opferman JT, Sun J, Hu Q, Agulnik AA, Bishop CE, Thompson CB, Ashton-Rickardt PG. 1998. Long-term T cell memory requires the surface expression of self-peptide/major histocompatibilily complex molecules. Proc. Natl. Acad. Sci. USA 195:3065-70
55. Bergman RN, Hechter O. 1978. Neurohypophyseal hormone-responsive renal adenylate cyclase, IV. A random-hit matrix model for coupling in a hormone-sensitive adenylate cyclase system. J. Biol. Chem. 253:3238-50
56. McKeithan TW. 1995. Kinetic proofreading in T-cell receptor signal transduclion. Proc. Natl. Acad. Sci. USA 92:5042-46
57. Germain RN, Levine BH, Madrenas J. 1995. The T-cell receptor as a diverse signal transduction machine. Immunologisit 3/4:113-21
58. Jameson SC, Bevan MJ. 1995. T cell receptor antagonists and partial agonists. Immunity 2:1-11
59. Sloan-Lancaster J, Allen PM. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1-27
60. Madrenas J, Germain RN, 1996. Variant TCR ligands: New insights into the molecular basis of antigen-dependent signal transduction and T cell activation. Semin. Immunol. 8:83-101
61. Kersh GJ, Allen PM. 1996. Essential flexibility in the T-cell recognition of antigen. Nature 380:495-98
62. Mannie MD. 1991. A unified model for T cell antigen recognition and thymic selection of the T cell repertoire. J. Theor. Biol. 151:169-92
63. Janeway CA Jr. 1995. Ligands for the T-cell receptor: hard times for avidity models. Immunol. Today 16:223-25
64. Evavold BD, Sloan-Lancaster J, Wilson KJ, Rothbard JB, Allen PM. 1995. Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. Immunity 2:655-63
65. Williams O, Tarazona R, Wack A, Marker N, Roderick K, Kioussis D. 1998. Interactions with multiple peptide ligands determine the fate of developing thymocytes. Proc. Natl. Acad. Sci. USA 95:5706-11
66. Evavold BD, Allen PM. 1991. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252:1308-10
67. De Magistris MT, Alexander J, Coggeshall M, Altman A, Gaeta FC, Grey HM, Sette A. 1992. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68:625-34
68. Racioppi L, Ronchese F, Matís LA, Germain RN. 1993. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling. J. Exp. Med. 177:1047-60
69. Jameson SC, Carbone FR, Bevan MJ. 1993. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177:1541-50
70. Marx J. 1995. The T cell receptor begins to reveal its many facets. Science 267:459-60
71. Valitutti S, Müller S, Dessing M, Lanzavecchia A. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917-21
72. Itoh Y, Germain RN. 1997. Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ T cells, J. Exp. Med. 186:757-66
73. Bachmann MF, Oxenius A, Speiser DE, Mariathasan S, Hengartner H, Zinkernagel RM, Ohashi PS. 1997. Peptide-induced T cell receptor down-regulation on naive T cells predicts agonist/partial agonist properties and strictly correlates with T cell activation. Eur. J. Immunol. 27:2195-203
74. Carballido JM, Faith A, Carballido-Perrig N, Blaser K. 1997. The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific T helper cells. Eur. J. Immunol. 27:515-21
75. Nicholson LB, Waldner H, Carrizosa AM, Sette A, Collins M, Kuchroo VK. 1998. Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity. Proc. Natl. Acad. Sci. USA 95:264-69
76. Hemmer B, Stefanova I, Vergelli M, Germain RN, Martin R. 1998. Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells. J. Immunol. 160:5807-14
77. Busch R, Strang G, Howland K, Rothbard JB. 1990. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. Int. Immunol. 2:443-51
78. Rudensky A, Rath S, Preston HP, Murphy DB, Janeway CA Jr. 1991. On the complexity of self. Nature 353:660-62
79. Murphy DB, Rath S, Pizzo E, Rudensky AY, George A, Larson JK, Janeway CA Jr. 1992. Monoclonal antibody detection of a major self peptide - MHC class-II complex. J. Immunol. 148:3483-91
80. Zhong G, Reis e Sousa C, Germain RN. 1997. Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro. J. Exp. Med. 186:673-82
81. Zhong G, Reis e Sousa C, Germain RN. 1997. Production, specificity, and functionality of monoclonal antibodies to specific peptide:MHC class II complexes formed by active processing of exogenous protein. Proc. Natl. Acad. Sci. USA 94:13856-61
82. Dadaglio G, Nelson CA, Deck MB, Petzold SJ, Unanue ER. 1997. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity 6:727-38
83. Ikagawa S, Matsushita S, Chen YZ, Ishikawa T, Nishimura Y. 1996. Single amino acid substitutions on a Japanese cedar pollen allergen (Cry j l)-derived peptide induced alterations in human T cell responses and T cell receptor antagonism. J. Allergy Clin. Immunol. 97:53-64
84. Combadiere B, Reis e Sousa C, Germain RN, Lenardo MJ. 1998. Selective induction of apoptosis in mature T lymphocytes by variant T cell receptor ligands. J. Exp. Med. 187:349-55
85. Lenardo MJ. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858-61
86. Vergelli M, Hemmer B, Kalbus M, Vogt AB, Ling N, Conlon P, Coligan JB, McFarland H, Martin R. 1997, Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells. J. Immunol. 158:3746-52
87. Corr M, Slanetz AE, Boyd LF, Jelonek MT, Khilko S, al-Ramadi BK, Kim YS, Maher SE, Bothwell AL, Margulies DH. 1994. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 265:946-49
88. k complexes: correlation of the dissociation rate with T-cell responsiveness. Proc. Natl. Acad. Sci. USA 91:12862-66
89. Seth A, Stern LJ, Ottenhoff TH, Engel T, Owen MJ, Lamb JR, Klausner RD, Wiley DC. 1994. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature 369:324-27
90. al-Ramadi BK, Jelonek MT, Boyd LF, Margulies DH, Bothwell AL. 1995. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. J. Immunol. 155:662-73
91. Garcia KC, Scott CA, Brunmark A, Carbone FR, Peterson PA, Wilson IA, Teyton L. 1996. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 384:577-81
92. Alam SM, Travers PJ, Wung JL, Nasholds W, Redpath S, Jameson SC, Gascoigne NR. 1996. T-cell-receptor affinity and thymocyte positive selection. Nature 381:616-20
93. Seibel JL, Wilson N, Kozono H, Marrack P, Kappler JW. 1997. Influence of the NH2-terminal amino acid of the T cell receptor alpha chain on major histocompatibility complex (MHC) class II + peptide recognition. J. Exp. Med. 185:1919-27
94. Matsui K, Boniface JJ, Reay PA, Schild H, Fazekas de St. Groth B, Davis MM. 1991. Low affinity interaction of peptide-MHC complexes with T cell receptors. Science 254:1788-91
95. Weber S, Traunecker A, Oliveri F, Gerhard W, Karjalainen K. 1992, Specific low-affinity recognition of major histocompatibilily complex plus peptide by soluble T-cell receptor. Nature 356:793-96
96. Sykulev Y, Brunmark A, Jackson M, Cohen RJ, Peterson PA, Eisen HN. 1994. Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes. Immunity 1:15-22
97. Sykulev Y, Brunmark A, Tsomides TJ, Kageyama S, Jackson M, Peterson PA, Eisen HN. 1994. High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc. Natl. Acad. Sci. USA 91:11487-91
98. Luescher IF, Vivier E, Layer A, Mahiou J, Godeau F, Malissen B, Romero P. 1995. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 373:353-56
99. d-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative. J. Exp. Med. 185:629-40
100. Margulies DH. 1997. Interactions of TCRs with MHC-peptide complexes: a quantitative basis for mechanistic models. Curr. Opin. Immunol. 9:390-95
101. Davis MM, Boniface JJ, Reich Z, Lyons D, Hampl J, Arden B, Chien Y. 1998. Ligand recognition by αβ T cell receptors. Annu. Rev. Immunol. 16:523-44
102. Andersen PS, Stryhn A, Hansen BE, Fugger L, Engberg J, Buus S. 1996. A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. Proc. Natl. Acad. Sci. USA 93:1820-24
103. Tan L, Turner J, Weiss A. 1991. Regions of the T cell receptor α and β chains that are responsible for interactions with CD3. J. Exp. Med. 173:1247-56
104. Cosson P, Bonifacino JS, 1992. Role of transmembrane domain interactions in the assembly of class II MHC molecules. Science 258:659-62
105. Rutledge T, Cosson P, Manolios N, Bonifacino JS, Klausner RD. 1992. Transmembrane helical interactions - ζ-chain dimerization and functional association with the T-cell antigen receptor. EMBO J. 11:3245-54
106. Campbell KS, Backstrom BT, Tiefenthaler G, Palmer E. 1994. CART: a conserved antigen receptor transmembrane motif. Semin. Immunol. 6:393-410
107. Dietrich J, Neisig A, Hou X, Wegener AM, Gajhede M, Geisler C. 1996. Role of CD3γ in T cell receptor assembly. J. Cell Biol. 132:299-310
108. Backstrom BT, Milia E, Peter A, Jaureguiberry B, Baldari CT, Palmer E. 1996. A motif within the T cell receptor α chain constant region. Immunity 5:437-47
109. GhendlerY, Smolyar A, Chang HC, Reinherz EL. 1998. One of the CD3ε subunits within a T cell receptor complex lies in close proximity to the Cβ FG loop. J. Exp. Med. 187:1529-36
110. Shaw AS, Dustin ML. 1997. Making the T cell receptor go the distance: a topological view of T cell activation. Immunity 6:361-69
111. d to CDS: interaction with the amino terminus of a mature cell surface protein. J. Immunol. 160:2809-14
112. Janeway CA Jr. 1991. The co-receptor function of CD4. Semin. Immunol. 3:153-60
113. Lyons DS, Lieberman SA, Hampl J, Boniface JJ, Chien Y, Berg LJ, Davis MM. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5:53-61
114. Kent UM, Mao SY, Wofsy C, Goldstein B, Ross S, Metzger H. 1994. Dynamics of signal transduction after aggregation of cell-surface receptors: studies on the type 1 receptor for IgE. Proc. Natl. Acad. Sci. USA 91:3087-91
115. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. 1994. The fidelity of protein synthesis is improved by two proofreading mechanisms. In Molecular Biology of the Cell, ed. B Alberts, D Bray, J Lewis, et al, pp. 239-41. New York/London: Garland
116. Rabinowitz JD, Beeson C, Lyons DS, Davis MM, McConnell HM. 1996. Kinetic discrimination in T-cell activation. Proc Natl. Acad. Sci. USA 93:1401-5
117. Chan AC, Desai DM, Weiss A, 1994. The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction. Annu. Rev. Immunol. 12:555-92
118. Weiss A, Iwashima M, Irving B, van Oers NS, Kadlecek TA, Straus D, Chan A. 1994. Molecular and genetic insights into T cell antigen receptor signal transduction. Adv. Exp. Med. Biol. 365:53-62
119. Zhao H, Koretzky GA. 1997. Regulation of signal transduction through the T cell antigen receptor. J. Lab. Clin. Med. 130:126-31
120. Samelson LK, Patel MD, Weissman AM, Harford JB, Klausner RD. 1986. Antigen activation of murine T cells induces tyrosine phosphorylation of a polypeptide associated with the T cell antigen receptor. Cell 46:1083-90
121. June CH, Fletcher MC, Ledbetter JA, Samelson LE. 1990. Increases in tyrosine phosphorylation are detectable be fore phospholipase C activation after T cell receptor stimulation. J. Immunol. 144:1591-99
122. Straus DB, Weiss A, 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70:585-93
123. Samelson LE, Phillips AF, Luong ET, Klausner RD. 1990. Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor. Proc. Natl. Acad. Sci. USA 87:4358-62
124. Iwashima M, Irving BA, van Oers NS, Chan AC, Weiss A. 1994. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 263:1136-39
125. Wange RL, Samelson LE. 1996. Complex complexes: signaling at the TCR. Immunity 5:197-205
126. Reth M. 1992. Antigen receptors on B lymphocytes. Annu. Rev. Immunol. 10:97-121
127. Isakov N. 1997. ITIMs and ITAMs. The Yin and Yang of antigen and Fc receptor-linked signaling machinery. Immunol. Res. 16:85-100
128. Kersh EN, Shaw AS, Allen PM. 1998. Fidelity of T cell activation through multistep T cell receptor ζ phosphorylation. Science 281:572-75
129. Ravichandran KS, Lee KK, Songyang Z, Cantley LC, Burn H, Burakoff SJ. 1993. Interaction of She with the C chain of the T cell receptor upon T cell activation. Science 262:902-5
130. Osman N, Lucas SC, Turner H, Cantrell D. 1995. A comparison of the interaction of She and the tyrosine kinase ZAP-70 with the T cell antigen receptor zeta chain tyrosine-based activation motif. J. Biol. Chem. 270:13981-86
131. Zenner G, Vorherr T, Mustelin T, Burn P. 1996. Differential and multiple binding of signal transducing molecules to the ITAMs of the TCR-ζ chain. J. Cell Biochem. 63:94-103
132. Koyasu S, Tse AG, Moingeon P, Hussey RE, Mildonian A, Hannisian J, Clayton LK, Reinherz EL. 1994. Delineation of a T-cell activation motif required for binding of protein tyrosinc kinases containing tandem SH2 domains. Proc. Natl. Acad. Sci. USA 91:6693-97
133. Gauen LK, Zhu Y, Letoumeur F, Hu Q, Bolen JB, Matis LA, Klausner RD, Shaw AS. 1994. Interactions of p59fyn and ZAP-70 with T-cell receptor activation motifs: defining the nature of a signalling motif. Mol. Cell Biol. 14:3729-41
134. Isakov N, Wange RL, Burgess WH, Watts JD, Aebersold R, Samelson LE. 1995. ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity. J. Exp. Med. 181:375-80
135. Bu JY, Shaw AS, Chan AC. 1995. Analysis of the interaction of ZAP-70 and syk protein-tyrosine kinases with the T-cell antigen receptor by plasmon resonance. Proc. Natl. Acad. Sci. USA 92:5106-10
136. Hatada MH, Lu X, Laird ER, Green J, Morgenstern JP, Lou M, Marr CS, Phillips TB, Ram MK, Theriault K, et al. 1995. Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature 377:32-38
137. Couture C, Baier G, Altman A, Mustelin T. 1994. p56lck-independent activation and tyrosine phosphorylation of p72syk by T-cell antigen receptor/CD3 stimulation. Proc. Natl. Acad. Sci. USA 91:5301-5
138. Chan AC, Dalton M, Johnson R, Kong GH, WangT, Thoma R, Kurosaki T. 1995. Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function. EMBO J. 14:2499-508
139. Wange RL, Guitian R, Isakov N, Watts JD, Aebersold R, Samelson LE. 1995. Activating and inhibitory mutations in adjacent tyrosines in the kinase domain of ZAP-70. J. Biol. Chem. 270:18730-33
140. Kong G, Dalton M, Wardenburg JB, Straus D, Kurosaki T, Chan AC. 1996. Distinct tyrosine phosphorylation sites in ZAP-70 mediate activation and negative regulation of antigen receptor function. Mol. Cell Biol. 16:5026-35
141. Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP, Samelson LE. 1998. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell 92:83-92
142. Bruyns E, Marie-Cardine A, Kirchgessner H, Sagolla K, Shevchenko A, Mann M, Autschbach F, Bensussan A, Meuer S, Schraven B. 1998, T cell receptor (TCR) interacting molecule (TRIM), a novel disulfide-linked dimer associated with the TCR-CD3-ζ complex, recruits intracellular signaling proteins to the plasma membrane. J. Exp. Med. 188:561-75
143. Pawson T, Scott JD. 1997. Signaling through scaffold, anchoring, and adaptor proteins. Science 278:2075-80
144. Jackman JK, Motto DG, Sun Q, Tanemoto M, Turck CW, Peltz GA, Koretzky GA, Findell PR. 1995. Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells. J. Biol. Chem. 270:7029-32
145. Wu J, Motto DG, Koretzky GA, Weiss A. 1996. Vav and SLP-76 interact and functionally cooperate in TL-2 gene activation. Immunity 4:593-602
146. Raab M, da Silva AJ, Findell PR, Rudd CE. 1997. Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCR. Immunity 6:155-64
147. Yablonski D, Kuhne MR, Kadlecek T, Weiss A. 1998, Uncoupling of nonreceptor tyrosine kinases from PLC-γ1 in an SLP-76-deficient T cell. Science 281:413-16
148. Weiss A, Imboden JB. 1987. Cell surface molecules and early events involved in human T lymphocyte activation. Adv. Immunol. 41:1-38
149. Lewis RS, Cahalan MD. 1995. Potassium and calcium channels in lymphocytes. Annu Rev. Immunol. 13:623-53
150. Crabtree GR, Clipstone NA. 1994. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem. 63:1045-83
151. Jain J, Loh C, Rao A. 1995. Transcriptional regulation of the 1L-2 gene. Curr. Opin. Immunol. 7:333-42
152. Karin M, Liu Z, Zandi E. 1997. AP-I function and regulation. Curr. Opin. Cell Biol. 9:240-46
153. Ullman KS, Northrop JP, Verweij CL, Crabtree GR. 1990. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu. Rev. Immunol. 8:421-52
154. Rabinowitz JD, Beeson C, Wulfing C, Tate K, Allen PM, Davis MM, McConnell HM. 1996. Altered Tcell receptor ligands trigger a subset of early T cell signals. Immunity 5:125-35
155. Beeson C, Rabinowitz J, Tate K, Gutgemann I, Chien YH, Jones PP, Davis MM, McConnell HM. 1996. Early biochemical signals arise from low affinity TCR-ligand reactions at the cell-cell interface. J. Exp. Med. 184:777-82
156. Sloan-Lancaster J, Steinberg TH, Allen PM. 1996. Selective activation of the calcium signaling pathway by altered peptide ligands. J. Exp. Med. 184:1525-30
157. Wulfing C, Rabinowitz JD, Beeson C, Sjaastad MD, McConnell HM, Davis MM. 1997. Kinetics and extent of T cell activation as measured with the calcium signal. J. Exp. Med. 185:1815-25
158. Chan LA, Bluestone JA, Madrenas J. 1998. Dissociation of intracellular signaling pathways in response to partial agonist ligands of the T cell receptor. J. Exp. Med. 187:1699-709
159. Sloan-Lancaster J, Shaw AS, Rothbard JB, Allen PM. 1994. Partial T cell signaling: altered phospho-ζ and lack of ZAP-70 recruitment in APU-induced T cell anergy, Cell 79:913-22
160. Madrenas J, Wange RL, Wang JL, Isakov N, Samelson LE, Germain RN. 1995. ζ phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267:515-18
161. Reis e Sousa C, Levine EH, Germain RN. 1996. Partial signaling by CD8+ T cells in response to antagonist ligands. J. Exp. Med. 184:149-57
162. La Face DM, Couture C, Anderson K, Shih G, Alexander J, Sette A, Mustelin T, Altman A, Grey HM. 1997. Differential T cell signaling induced by antagonist peptide-MHC complexes and the associated phenotypic responses. J. Immunol. 158:2057-64
163. König R, Fleury S, Germain RN. 1996. The structural basis of CD4-MHC class II interactions: coreceptor contributions to T cell receptor antigen recognition and oligomerizalion-depcndem signal transduction. Curr. Top. Microbiol. Immunol. 205:19-46
164. Madrenas J, Chau LA, Smith J, Blueslone JA, Germain RN. 1997. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonistypartial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185:219-30
165. Hampl J, Chien Y-H, Davis MM. 1997. CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity 7:379-85
166. Jameson SC, Hogquist KA, Bevan MJ. 1994, Specificity and flexibility in thymic selection. Nature 369:750-52
167. Mannie MD, Rosser JM, White GA. 1995. Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and noncfficacious signals during T cell antigen recognition. J. Immunol. 154:2642-54
168. Vidal K, Hsu BL, Williams CB, Allen PM. 1996. Endogenous altered peptide ligands can affect peripheral T cell responses. J. Exp. Med. 183:1311-21
169. Viola A, Lanzavecchia A. 1996. T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104-6
170. Kim DT, Rothbard JB, Bloom DD, Fathman CG. 1996. Quantitative analysis of T cell activation: role of TCR/ligand density and TCR affinity. J. Immunol. 156:2737-42
171. Bergman M, Mustelin T, Oetken C, Partanen J, Flint NA, Amrein KE, Autero M, Burn P, Alitalo K. 1992. The human p50csk tyrosine kinase phosphorylates p56lck at Tyr-505 and down regulates its catalytic activity. EMBO J. 11:2919-24
172. Sondhi D, Xu W, Songyang Z, Eck MJ, Cole PA, 1998. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism. Biochemistry 37:165-72
173. Bougeret C, Delaunay T, Romero F, Jullien P, Sabe H, Hanafusa H, Benarous R, Fischer S. 1996. Detection of a physical and functional interaction between Csk and Lck which involves the SH2 domain of Csk and is mediated by autophosphorylation of Lck on tyrosine 394. J. Bioi. Chem. 271:7465-72
174. Chow LM, Fournel M, Davidson D, Veillette A. 1993. Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk. Nature 365:156-60
175. Mustelin T, Williams S, Tailor P, Couture C, Zenner G, Burn P, Ashwell JD, Altman A. 1995. Regulation of the p70zap tyrosine protein kinase in T cells by the CD45 phosphotyrosine phosphatase. Eur. J. Immunol. 25:942-46
176. Furukawa T, Itoh M, Krueger NX, Streuli M, Saito H. 1994. Specific interaction of the CD45 protein-tyrosine phosphatase with tyrosine-phosphorylated CD3ζ chain. Proc. Natl. Acad. Sci. USA 91:10928-32
177. Murphy MA, Schnall RG, Venter DJ, Barnett L, Bertoncello I, Thien CB,
178. Thompson CB, Allison JP. 1997. The emerging role of CTLA-4 as an immune attenuator. Immunity 7:445-50
179. Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561-69
180. Krummel MF, Allison JP. 1995, CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459-65
181. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Thompson CB, Bluestone JA. 1994. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405-13
182. Marengere LE, Waterhouse P, Duncan GS, Mittrucker HW, Feng GS, Mak TW. 1996. Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272:1170-73
183. Linsley PS, Greene JL, Tan P, Bradshaw J, Ledbetter JA, Anasetti C, Damle NK. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated lymphocytes-T. J. Exp. Med. 176:1595-604
184. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW. 1995. Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270:985-88
185. Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3:541-47
186. Chambers CA, Sullivan TJ, Allison JP. 1997. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity 7:885-95
187. Tonks NK, Neel BG. 1996. From form to function: signaling by protein tyrosine phosphatases. Cell 87:365-68
188. Kozlowski M, Mlinaric-Rascan I, Feng GS, Shen R, Pawson T, Siminovitch KA. 1993. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice. J. Exp. Med. 178:2157-63
189. Shultz LD, Schweitzer PA, Rajan TV, Yi T, Ihle JN, Matthews RJ, Thomas ML, Beier DR. 1993. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445-54
190. Tsui HW, Siminovitch KA, de Souza L, Tsui FW. 1993. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat. Genet. 4:124-29
191. Pani G, Fischer KD, Mlinaric-Rascan I, Siminovitch KA. 1996. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase. J. Exp. Med. 184:839-52
192. Plas DR, Johnson R, Pingel JT, Matthews RJ, Dalton M, Roy G, Chan AC, Thomas ML. 1996. Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling. Science 272:1173-76
193. Robbins DJ, Zhen E, Cheng M, Xu S, Ebert D, Cohb MH. 1994, MAP kinases ERK1 and ERK2: pleiotropic enzymes in a ubiquitous signaling network. Adv. Cancer Res. 63:93-116
194. Winkler DG, Park I, Kim T, Payne NS, Walsh CT, Strominger JL, Shin J. 1993. Phosphorylation of Ser-42 and Ser-59 in the N-terminal region of the tyrosine kinase p56lck. Proc. Natl. Acad. Sci. USA 90:5176-80
195. August A, Dupont B. 1996. Association between mitogen-activated protein kinase and the ζ chain of the T cell receptor (TcR) with the SH2,3 domain of p56lck. Differential regulation by TcR cross-linking. J. Biol. Chem. 271:10054-59
196. Lorenz U, Ravichandran KS, Pei D, Walsh CT, Burakoff SJ, Neel BG. 1994, Lck-dependent tyrosyl phosphorylation of the phosphotyrosine phosphatase SH-PTP1 in murine T cells. Mol. Cell Biol. 14:1824-34
197. Songyang Z, Carraway III KL, Eck MJ, Harrison SC, Feldman RA, Mohammadi M, Schlessinger J, Hubbard SR, Smith DP, Eng C, Lorenzo ML, Ponder BAJ, Mayer BJ, Cantley LC. 1995. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 373:536-39
198. Pei D, Lorenz U, Klingmuller U, Neel BG, Walsh CT. 1994. Intramolecular regulation of protein tyrosine phosphatase SH-PTP1: a new function for Src homology 2 domains. Biochemistry 33:15483 93
199. Pei D, Wang J, Walsh CT. 1996. Differential functions of the two Src homology 2 domains in protein tyrosine phosphatase SH-PTP1. Proc. Natl. Acad. Sci. USA 93:1141-45
200. Grossman Z, Paul WE. 1992. Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses. Proc. Natl. Acad. Sci. USA 89:10365-69
201. Palsson BO, Lightfoot EN. 1985. Mathematical modelling of dynamics and control in metabolic networks. IV. Local stability analysis of single biochemical control loops. J. Theor. Biol. 113:261-77
202. Dolmetsch RE, Xu K, Lewis RS. 1998. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 392:933-36
203. Li W, Llopis J, Whitney M, Zlokarnik G, Tsien RY. 1998. Cell-permeant caged InsP3 ester shows that Ca2+ spike frequency can optimize gene expression. Nature 392:936-41
204. Constant S, Pfeiffer C, Woodard A, Pasqualini T, Bottomly K. 1995. Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. J. Exp. Med. 182:1591-96
205. Hosken NA, Shibuya K, Heath AW, Murphy KM, O'Garra A. 1995. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Exp. Med. 182:1579-84
206. Valitutti S, Muller S, Salio M, Lanzavecchia A. 1997. Degradation of T cell receptor (TCR)-CD3-ζ complexes after antigenic stimulation. J. Exp. Med. 185: 1859-64
207. Cai Z, Kishimoto H, Brunmark A, Jackson MR, Peterson PA, Sprent J. 1997. Requirements for peptide-induced T cell receptor downregulation on naive CDS+ T cells. J. Exp. Med. 185:641-51
208. Salio M, Valitutti S, Lanzavecchia A. 1997. Agonist-induced T cell receptor down-regulation: molecular requirements and dissociation from T cell activation. Eur. J. Immunol. 27:1769-73
209. Valitutti S, Müller S, Cella E, Padovan E, Lanzavecchia A. 1995. Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 375:148-51
210. Ledbetter JA, Deans JP, Aruffo A, Grosmaire LS, Kanner SB, Bolen JB, Schieven GL. 1993. CD4, CD8 and the role of CD45 in T-cell activation. Curr. Opin. Immunol. 5:334-40
211. Kupfer A, Singer SJ. 1989. Cell biology of cytotoxic and helper T cell functions: immunofluorescence microscopic studies of single cells and cell couples. Annu. Rev. Immunol. 7:309-37
212. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. 1998. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395:82-86
213. Saizawa K, Rojo J, Janeway CA Jr. 1987. Evidence for a physical association of CD4 and the CD3:αβ T-cell receptor. Nature 328:260-63
214. Anderson P, Blue ML, Schlossman SF. 1988. Comodulation of CD3 and CD4. Evidence for a specific association between CD4 and approximately 5% of the CD3:T cell receptor complexes on helper T lymphocytes. J. Immunol. 140:1732-37
215. Wu H, Kwong PD, Hendrickson WA. 1997. Dimeric association and segmental variability in the structure of human CD4. Nature 387:527-30
216. König R, Shen X, Germain RN. 1995. Involvement of both major histocompatibility complex class II α and β chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 182:779-87
217. Cherry RJ, Wilson KM, Triantafilou K, O'Toole P, Morrison IE, Smith PR, Fernandez N. 1998. Detection of dimers of human leukocyte antigen (HLA)-DR on the surface of living cells by single-particle fluorescence imaging. J. Cell Biol. 140:71-79
218. Sakihama T, Smolyar A, Reinherz EL. 1995. Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp 120. Proc. Natl. Acad. Sci. USA 92:6444-48
219. Sakihama T, Smolyar A, Reinherz EL. 1995. Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules. Immunol. Today 16:581-87
220. Reich Z, Boniface JJ, Lyons DS, Borochov N, Wachtel EJ, Davis MM. 1997. Ligand-specific oligomerization of T-cell receptor molecules. Nature 387:617-20
221. Germain RN. 1997. T-cell signaling: the importance of receptor clustering. Curr. Biol. 7: R640-44
222. Posner RG, Lee B, Conrad DH, Holowka D, Baird B, Goldstein B. 1992. Aggregation of IgE receptor complexes on rat basophilic leukemia cells does not change the intrinsic affinity but can alter the kinetics of the ligand-IgE interaction. Biochemistry 31:5350-56
223. Davis SJ, van der Merwe PA. 1996. The structure and ligand interactions of CD2: implications for T-cell function. Immunol. Today 17:177 87
224. Torigoe C, Inman JK, Metzger H. 1998. An unusual mechanism for ligand antagonism. Science 281:568-72
225. Janeway CA Jr, Kupfer A, Viret C, Boursalian T, Goverman J, Bottomly K, Sant' Angelo D. 1998, T-cell development, survival, and signalling. A new concept of the role of self-peptide:self-MHC complexes. Immunologist 6:5-12
226. Ferrell JE Jr, Machleder EM. 1998. The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes. Science 280:895-98
227. Koshland DE Jr, Goldbeter A, Stock JB. 1982. Amplification and adaptation in regulatory and sensory systems. Science 217:220-25
228. Goldbeter A, Koshland DE Jr. 1981. An amplified sensitivity arising from covalent modification in biological systems. Proc. Natl. Acad. Sci. USA 78:6840-44
229. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17-27
230. Pircher H, Rohrer UH, Moskophidis D, Zinkemagel RM, Hengartner H. 1991. Lower receptor avidity required for thymic clonal deletion than for effector T-cell function. Nature 351:482-85
231. Selzda E, Kundig TM, Thomson CT, Aoki K, Mak SY, Mayer JP, Zamborelli T, Nathenson SG, Ohashi PS. 1996. Mature T cell reactivity altered by peptide agonist that induces positive selection. J. Exp. Med. 183:1093-104
232. Grossman Z, Singer A. 1996. Tuning of activation thresholds explains flexibility in the selection and development of T cells in the thymus. Proc. Natl. Acad. Sci. USA 93:14747-52
233. Smyth LA, Williams O, Huby RDJ, Norton T, Acuto O, Ley SC, Kioussis D. 1998. Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes. Proc. Natl. Acad. Sci. USA 95:8193-98
234. Wiest DL, Ashe JM, Abe R, Bolen JB, Singer A. 1996. TCR activation of ZAP70 is impaired in CD4+CD8+ thymocytes as a consequence of intrathymic interactions that diminish available p56lck. Immunity 4:495-504
235. Lucas B, Germain RN. 1996. Unexpectedly complex regulation of CD4/CD8 coreceptor expression supports a revised model for CD4+CD8+ thymocyte differentiation. Immunity 5:461-77
236. Olszowy MW, Leuchtmann PL, Veillette A, Shaw AS. 1995. Comparison of p56lck and p59fyn protein expression in thymocyte subsets, peripheral T cells, NK cells, and lymphoid tell lines. J. Immunol. 155:4236-40
237. Alberola-Ila J, Hogquist KA, Swan KA, Bevan MJ, Perlmutter RM. 1996. Positive and negative selection invoke distinct signaling pathways, J. Exp. Med. 184:9-18
238. Alberola-Ila J, Forbush KA, Seger R, Krebs EG, Perlmutter RM. 1995. Selective requirement for MAP kinase activation in thymocyte differentiation. Nature 373:620 23
239. Sharp LL, Schwarz DA, Bott CM, Marshall CJ, Hedrick SM. 1997. The influence of the MAPK pathway on T cell lineage commitment. Immunity 7:609-18
240. Kisielow P, Miazek A. 1995. Positive selection of T cells: rescue from programmed cell death and differentiation require continual engagement of the T cell receptor. J. Exp. Med. 181:1975-84
241. Schmitt S, Muller KP, Kyewski BA. 1997. Two separable T cell receptor signals reconstitute positive selection of CD4 lineage T cells in vivo. Eur. J. Immunol. 27:2139-44
242. Ono M, Okada H, Holland S, Yanagi S, Kurosaki T, Ravetch JV. 1997. Deletion of SHIP or SHP-I reveals two distinct pathways for inhibitory signaling. Cell 90:293-301
243. Duke RC. 1989. Self recognition by T cells. I. Bystander killing of target cells bearing syngeneic MHC antigens. J. Exp. Med. 170:59-71
244. van Oers NSC, Killeen N, Weiss A. 1994. ZAP-70 is constitutively associated with tyrosine-phosphorylatedTCRζ in murine thymocytes and lymph node T cells. Immunity 1:675-85
245. van Oers NS, Tao W, Watts JD, Johnson P, Aebersold R, Teh HS. 1993. Constitutive tyrosine phosphorylation of the T-cell receptor (TCR) ζ subunit: regulation of TCR-associated protein tyrosine kinase activity by TCR ζ. Mol. Cell Biol. 13:5771-80
246. Matsushita S, Kohsaka H, Nishimura Y. 1997. Evidence for self and nonself peptide partial agonists that prolong clonal survival of mature T cells in vitro. J. Immunol. 158:5685-91
247. Schwartz RH. 1985-T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu. Rev. Immunol. 3:237-61
248. Ronchese F, Schwartz RH, Germain RN. 1987. Functionally distinct subsites on a class II major histocompatibility complex molecule. Nature 329:254-56
249. Parkhurst MR, Salgaller ML, Southwood S, Robbins PF, Sette A, Rosenberg SA, Kawakami Y. 1996. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp 100 modified at HLA-A*0201-binding residues. J. Immunol. 157:2539-48
250. Hemmer B, Vergelli M, Gran B, Ling N, Conlon P, Pinilla C, Houghten R, McFarland HF, Martin R. 1998. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. J. Immunol. 160:3631-36
251. Hemmer B, Vergelli M, Pinilla C, Houghten R, Martin R. 1998. Probing degeneracy in T-cell recognition using peptide combinatorial libraries. Immunol. Today 19:163-68
252. Sprent J, Lo D, Gao EK, Ron Y. 1988. T cell selection in the thymus. Immunol. Rev. 101:173-90
253. Schild H, Rotzschke O, Kalbacher H, Rammensee HG. 1990. Limit of T cell tolerance to self proteins by pcptide presentation. Science 247:1587-89
254. Salemi S, Caporossi AP, Boffa L, Longobardi MG, Barnaba V. 1995. HIVgp120 activates autoreactive CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing. J. Exp. Med. 181:2253-57
255. Liu GY, Fairchild PJ, Smith RM, Prowle JR, Kioussis D, Wraith DC. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3:407-15
256. Oldstone MB. 1987. Molecular mimicry and autoimmune disease. Cell 50:819-20
257. Wucherpfennig KW, Strominger JL. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695-705
258. d-restricted cytotoxic T lymphocytes. J. Exp. Med. 173:849-58
259. Klenerman P, Zinkernagel RM. 1998. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 394:482-85
260. Klenerman P, Rowland JS, McAdam S, Edwards J, Daenke S, Lalloo D, et al. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369:403-7
261. Bertoletti A, Sette A, Chisari FV, Penna A, Levrero M, De Carli M, Fiaccadori F, Ferrari C. 1994. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369:407-10
262. Wiesenfeld K, Moss F. 1995, Stochastic resonance and the benefits of noise: from ice ages to crayfish and SQUIDs. Nature 373:33-36
263. Collins JJ, Chow CC, Imhoff TT. 1995. Stochastic resonance without tuning. Nature 376:236-38
264. Bray D, Levin MD, Morton-Firth CJ. 1998. Receptor clustering as a cellular mechanism to control sensitivity. Nature 393:85-88
265. Haughn L, Gratton S, Caron L, Sekaly RP, Veillette A, Julius M. 1992. Association of tyrosine kinase p56(lck) with CD4 inhibits the induction of growth through the αβ T-Cell receptor. Nature 358:328-31
266. Hetricoin EF, 3rd, Ito S, Williams BL, Audet S, Stancato LF, Gamero A, Clouse K, Grimley P, Weiss A, Beeler J, Finbloom DS, Shores KW, Abraham R, Lamer AC. 1997. Antiproliferative action of interferon-α requires components of T-cell-receptor signalling. Nature 390:629-32
267. Saito T. 1998. Negative regulation of T cell activation. Curr. Opin. Immunol. 10:313-21
268. Yi T, Mui AL, Krystal G, Ihle JN. 1993. Hematopoietic cell phosphatase associates with the interleukin-3 (IL-3) receptor β chain and down-regulates IL-3-induced tyrosine phosphorylation and mitogenesis. Mol. Cell Biol. 13:7577-86
269. Imani F, Rager KJ, Catipovic B, Marsh DG. 1997. Interleukin-4 (IL-4) induces phosphatidylinositol 3-kinase (p85) dephosphorylation. Implications for the role of SHP-1 in the IL-4 -induced signal in human B cells, J. Biol Chem. 272:7927-31
270. Migone TS, Cacalano NA, Taylor N, Yi T, Waldmann TA, Johnston JA. 1998. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type T-transformed T cells. Proc. Natl. Acad. Sci. USA 95:3845-50
271. Watts DJ, Strogatz SH. 1998. Collective dynamics of 'small-world' networks. Nature 393:440-42